UCrest Berhad (KLSE:UCREST)

Chimerix Income Statement

Financials in millions MYR. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Revenue	18.44	16.45	13.56	12.35	25.46
Revenue Growth (YoY)	12.08%	21.35%	9.80%	-51.50%	107.37%
Cost of Revenue	15.19	11.66	8.73	10.16	9.98
Gross Profit	3.25	4.79	4.83	2.19	15.48
Selling, General & Admin	4.37	7.99	7.8	23.96	14.06
Other Operating Expenses	-7.57	-7.06	-2.63	13.65	-7.72
Operating Expenses	-1.93	0.93	5.18	37.61	6.34
Operating Income	5.17	3.86	-0.35	-35.43	9.13
Interest Expense	-0.01	-0.01	-0.1	-0.1	-0.1
Interest & Investment Income	-	0.48	0.16	0.1	0.05
Currency Exchange Gain (Loss)	-	0.22	0.38	0.26	0.58
Other Non Operating Income (Expenses)	-	0.04	0.01	0.03	2.01
EBT Excluding Unusual Items	5.17	4.59	0.1	-35.13	11.67
Other Unusual Items	-	-	-	-	0.02
Pretax Income	5.17	4.59	0.1	-35.13	11.69
Income Tax Expense	-	-	-	-	0.12
Net Income	5.17	4.59	0.1	-35.13	11.57
Net Income to Common	5.17	4.59	0.1	-35.13	11.57
Net Income Growth	12.53%	4450.49%	-	-	-
Shares Outstanding (Basic)	744	741	641	622	531
Shares Outstanding (Diluted)	746	741	642	622	544
Shares Change (YoY)	0.66%	15.52%	3.18%	14.23%	17.32%
EPS (Basic)	0.01	0.01	0.00	-0.06	0.02
EPS (Diluted)	0.01	0.01	0.00	-0.06	0.02
EPS Growth	11.38%	3845.22%	-	-	-
Free Cash Flow	2.09	-3.74	-4.27	-4.97	-4.35
Free Cash Flow Per Share	0.00	-0.01	-0.01	-0.01	-0.01
Gross Margin	17.61%	29.12%	35.60%	17.72%	60.79%
Operating Margin	28.05%	23.47%	-2.58%	-286.92%	35.88%
Profit Margin	28.02%	27.91%	0.74%	-284.52%	45.44%
Free Cash Flow Margin	11.31%	-22.75%	-31.51%	-40.24%	-17.10%
EBITDA	6.29	4.43	0.22	-34.61	9.97
EBITDA Margin	34.09%	26.92%	1.65%	-280.30%	39.18%
D&A For EBITDA	1.11	0.57	0.57	0.82	0.84
EBIT	5.17	3.86	-0.35	-35.43	9.13
EBIT Margin	28.05%	23.47%	-2.58%	-286.92%	35.88%
Effective Tax Rate	-	-	-	-	1.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.